Indivior Operating Income 2012-2019 | INVVY

Indivior operating income from 2012 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Indivior Annual Operating Income
(Millions of US $)
2019 $178
2018 $292
2017 $193
2016 $149
2015 $346
2014 $562
2013 $695
2012 $884
2011 $872
Indivior Quarterly Operating Income
(Millions of US $)
2019-12-31 $-42
2019-09-30 $57
2019-06-30 $88
2019-03-31 $75
2018-12-31 $21
2018-09-30 $71
2018-06-30 $84
2018-03-31 $116
2017-12-31 $-115
2017-09-30 $63
2017-06-30 $117
2017-03-31 $128
2016-12-31 $72
2016-09-30 $-121
2016-06-30 $97
2016-03-31 $101
2015-12-31 $38
2015-09-30 $78
2015-06-30 $115
2015-03-31 $115
2014-12-31
2014-09-30 $131
2014-06-30 $162
2013-12-31
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.640B $0.785B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.739B 37.88
Takeda Pharmaceutical (TAK) Japan $58.011B 10.17
Astellas Pharma (ALPMY) Japan $32.072B 16.02
Eisai (ESALY) Japan $23.340B 43.48
UCB SA (UCBJF) Belgium $19.723B 0.00
Merck (MKGAF) Germany $14.934B 19.58
Grifols, S.A (GRFS) Spain $13.579B 16.88
Catalent (CTLT) United States $11.913B 46.05
Neurocrine Biosciences (NBIX) United States $11.154B 51.55
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.782B 41.38
Orion OYJ (ORINY) Finland $7.289B 32.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.270B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.744B 10.80
IPSEN SA ADR (IPSEY) France $6.676B 0.00
United Therapeutics (UTHR) United States $5.388B 10.21
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.192B 12.75
Evotec AG (EVTCY) Germany $4.119B 66.40
Nektar Therapeutics (NKTR) United States $4.112B 0.00
ChemoCentryx (CCXI) United States $3.711B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.303B 360.56
PTC Therapeutics (PTCT) United States $3.008B 0.00
FibroGen (FGEN) United States $2.913B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.603B 10.70
Cronos Group (CRON) Canada $2.334B 66.90
Pacira BioSciences (PCRX) United States $1.976B 40.45
Sage Therapeutics (SAGE) United States $1.826B 0.00
USANA Health Sciences (USNA) United States $1.794B 18.40
Xencor (XNCR) United States $1.702B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.699B 0.00
Heron Therapeutics (HRTX) United States $1.671B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.659B 0.00
Zogenix (ZGNX) United States $1.629B 0.00
Corcept Therapeutics (CORT) United States $1.618B 16.05
Akebia Therapeutics (AKBA) United States $1.587B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.560B 11.94
Portola Pharmaceuticals (PTLA) United States $1.406B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 15.06
Karyopharm Therapeutics (KPTI) United States $1.302B 0.00
Tilray (TLRY) Canada $1.260B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.200B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.002B 44.71
Translate Bio (TBIO) United States $0.984B 0.00
Endo (ENDP) Ireland $0.914B 1.42
ImmunoGen (IMGN) United States $0.801B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.769B 0.00
Aerie Pharmaceuticals (AERI) United States $0.684B 0.00
Molecular Templates (MTEM) United States $0.684B 0.00
Collegium Pharmaceutical (COLL) United States $0.681B 0.00
Ardelyx (ARDX) United States $0.616B 0.00
Trillium Therapeutics (TRIL) Canada $0.613B 0.00
Radius Health (RDUS) United States $0.568B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.508B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.499B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.485B 0.00
Flexion Therapeutics (FLXN) United States $0.458B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.448B 10.82
DURECT (DRRX) United States $0.445B 0.00
Organogenesis Holdings (ORGO) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.433B 16.91
Harpoon Therapeutics (HARP) United States $0.433B 0.00
MEI Pharma (MEIP) United States $0.410B 0.00
Ocular Therapeutix (OCUL) United States $0.377B 0.00
Calithera Biosciences (CALA) United States $0.368B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.346B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.319B 0.00
TherapeuticsMD (TXMD) United States $0.304B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.302B 0.00
Lannett Co Inc (LCI) United States $0.299B 6.55
Oasmia Pharmaceutical AB (OASMY) Sweden $0.279B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
CASI Pharmaceuticals (CASI) United States $0.264B 0.00
Redhill Biopharma (RDHL) Israel $0.244B 0.00
OptiNose (OPTN) United States $0.243B 0.00
Rafael Holdings (RFL) United States $0.236B 0.00
KalVista Pharmaceuticals (KALV) United States $0.209B 0.00
PROFOUND MEDICL (PROF) Canada $0.202B 0.00
Jounce Therapeutics (JNCE) United States $0.196B 4.68
VAXART, INC (VXRT) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 25.39
Taiwan Liposome (TLC) Taiwan $0.185B 0.00
Xeris Pharmaceuticals (XERS) United States $0.176B 0.00
IMV INC (IMV) Canada $0.176B 0.00
Aquestive Therapeutics (AQST) United States $0.173B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
Altimmune (ALT) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
Recro Pharma (REPH) United States $0.110B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
Otonomy (OTIC) United States $0.091B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.081B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
CV Sciences (CVSI) United States $0.078B 0.00
Hemispherx BioPharma (AIM) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
Onconova Therapeutics (ONTX) United States $0.076B 0.00
Heat Biologics (HTBX) United States $0.075B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Biomerica (BMRA) United States $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.36
Opiant Pharmaceuticals (OPNT) United States $0.050B 105.82
Natural Alternatives (NAII) United States $0.049B 0.00
IsoRay (ISR) United States $0.048B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.045B 0.00
GTx (ONCT) United States $0.045B 0.00
Lipocine (LPCN) United States $0.043B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 7.37
Neos Therapeutics (NEOS) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Novan (NOVN) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00